Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease

Brain Research

Volumn 730, Issue 1-2, 1996, Pages 232-237

  Cicchetti, Francesca ^a   Gould, Peter V ^a   Parent, André ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

basal ganglia; calcium binding protein; Huntington's chorea; neurodegenerative disorder; neurokinin receptor; striatum

Indexed keywords

CALRETININ; SUBSTANCE P;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NERVE DEGENERATION; PRIORITY JOURNAL;

EID: 0030593660     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00307-1     Document Type: Article

References (33)

1. [1] Albin, R.L., Reiner, A., Anderson. K.D., Dure, L.S., 4th, Handelin, B., Balfour, R., Whetsell, W.O., Jr., Penney, J.B. and Young, A.B., Preferential loss of striato-external pallidal projection neurons in presymptomatic Hutington's disease, Ann. Neurol., 31 (1992) 425-430.
2. [2] Albin, R.L. and Tagle, D.A., Genetics and molecular biology of Huntington's disease, Trends Neurosci., 18 (1995) 11-14.
3. [3] Aubry, J.-M., Lundström, K., Kawashima, E., Ayala, G., Schulz, P., Bartanusz, V. and Kiss, J.Z., NK1 receptor expression by cholinergic interneurones in human striatum, NeuroReport, 5 (1994) 1597-1600.
4. [4] Aubry, J.-M., Schultz, M.-F., Pagliusi, S., Schulz, P. and Kiss, J.Z., Coexpression of dopamine D2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum, Neuroscience, 53 (1993) 417-424.
5. [5] Bennett, B.D. and Bolam, J.P., Characterization of calretinin-immunoreactive structures in the striatum of the rat, Brain Res., 609 (1993) 137-148.
6. [6] Bolam, J.P., Ingham, C.A., Izzo, P.N., Levey, A.I., Rye, D.B., Smith, A.D. and Wainer, B. H., Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat, Brain Res., 397 (1986) 279-289.
7. [7] Dawbarn, D., DeQuidt, M.E. and Emson, P. C., Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease, Brain Res., 340 (1985) 251-261.
8. [8] Elde, R., Schalling, M., Ceccatelli, S., Nakanishi, S. and Hökfelt, T., Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors, Neurosci. Lett., 120 (1990) 134-138.
9. [9] Ferrante, R.J., Beal, M.F., Kowall, N.W., Richardson, E.P. Jr. and Martin, J.B., Selective sparing of a class of striatal neurons in Huntington's disease, Science, 230 (1985) 561-563.
10. [10] Gerfen, C.R., Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain, Brain Res., 556 (1991) 165-170.
11. [11] Graveland, G.A., Williams, R.S. and DiFiglia, M., Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease, Science, 227 (1985) 770-773.
12. [12] Hayden, M.R., Huntington's Chorea, Springer-Verlag, Berlin, 1981.
13. [13] Hedreen J.C. and Folstein S.E., Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol., 54 (1995) 105-120.
14. [14] Jacobowitz, D.M. and Winsky, L., Immunocytochemical localization of calretinin in the forebrain of the rat, J. Comp. Neurol., 304 (1991) 198-218.
15. [15] Kaneto, K., Shigemoto, R., Nakanishi, S. and Mizuno, N., Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons, Brain Res., 631 (1993) 297-303.
16. 28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease, Brain Res., 525 (1990) 209-214.
17. [17] Kowall, N.W., Ferrante, R.J. and Martin, J.B., Patterns of cell loss in Huntington's disease, Trends Neurosci., 10 (1987) 24-29.
18. [18] Levey, A.I., Bolam, P.J., Rye, D.B., Hallanger, A.E., Demuth, R.M., Mesulam, M.-M. and Wainer, B.H., A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride, J. Histochem. Cytochem., 34 (1986) 1449-1457.
19. [19] Martone, M.E., Armstrong, D.M., Young, S.J. and Groves, P.M., Ultrastructural examination of enkephalin and substance P input to cholinergic neurons within the rat neostriatum, Brain Res., 594 (1992) 253-262.
20. [20] Nakanishi, S., Mammalian tachykinin receptors, Annu. Rev. Neurosci., 14 (1991) 123-136.
21. [21] Parent, A., Cicchetti, F. and Beach, T.G., Striatal neurones displaying substance P (NK1) receptor immunoreactivity in human and non-human primates, NeuroReport, 6 (1995) 721-724.
22. [22] Parent, A., Cicchetti, F. and Beach, T.G., Calretinin-immunoreactive neurons in the human striatum, Brain Res., 674 (1995) 347-351.
23. [23] Parent, A., Csonka, C. and Etienne, P., The occurrence of large acetylcholinesterase-containing neurons in human neostriatum as disclosed in normal and Alzheimer-diseased brains, Brain Res., 291 (1984) 154-158.
24. [24] Reiner, A., Albin, R.L., Anderson, K.D., D'Amato, C.J., Penney, J.B. Jr. and Young, A.B., Differential loss of striatal projection neurons in Huntington's disease, Proc. Natl. Acad. Sci. USA, 85 (1988) 5733-5737.
25. [25] Résibois, A. and Rogers, J.H., Calretinin in the rat brain: an immunohistochemical study, Neuroscience, 46 (1992) 101-134.
26. [26] Richfield, E.K, Maguire-Zeiss, K.A., Vonkeman, H.E. and Voorn, P., Preferential loss of preproenkephalin versus preprotakykinin neurons from the striatum of Huntington's disease patients, Ann. Neurol., 38 (1995) 852-861.
27. [27] Rogers, J.H., Calretinin: A gene for a novel calcium binding protein expressed principally in neurons, J. Cell. Biol., 105 (1987) 1343-1353.
28. [28] Sapp, E., Ge, P., Aizawa, H., Bird, E., Penney, J.B. Jr., Young, A.B., Vonsattel, J.-P. and DiFiglia, M., Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis, Neuroscience, 64 (1995) 397-404.
29. [29] Schwaller, B., Buchwald, P., Blümcke. I., Celio, M.R. and Hunziker, W., Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin, Cell Calcium, 14 (1993) 639-648.
30. [30] Selden, N., Geula, C., Hersh, L. and Mesulam, M.-M., Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease, Neuroscience, 60 (1994) 621-636.
31. [31] Seto-Ohshima, A., Emson, P.C., Lawson, E., Mountjoy, C.Q. and Carrasco, L.H., Loss of matrix calcium-binding protein-containing neurons in Huntington's disease, Lancet, ii (1988) 1252-1255.
32. [32] Shigemoto, R., Nakaya, Y., Nomura, S., Ogawa-Meguro, R., Ohishi, H., Kaneko, T., Nakanishi, S. and Mizuno, N., Immunocytochemical localization of rat substance P receptor in the striatum, Neurosci. Lett., 153 (1993) 157-160.
33. [33] Vonsattel, J.-P., Meyers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson, E.P. Jr., Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol., 44 (1985) 559-577.